James A Shayman and Andrea S Kevrick Professor of Translational Medicine
Professor of Internal Medicine
Professor of Pharmacology
[email protected]
Available to mentor
Richard Auchus
Professor
Steroid biochemistry and related disorders; secondary causes of diabetes and their treatments.
-
MDWashington University in St. Louis School of Medicine, St Louis, 1988
-
PhDWashington University in St. Louis School of Medicine, St Louis, 1988
-
Center MemberSamuel and Jean Frankel Cardiovascular Center
-
Center MemberCaswell Diabetes Institute
-
Center MemberRogel Cancer Center
-
Center MemberCenter for Cell Plasticity and Organ Design
Steroid biochemistry and related disorders; secondary causes of diabetes and their treatments.
-
Reisch N, Auchus RJ. Endocrinol Metab Clin North Am, 2024 Sep; 53 (3): 391 - 407.Journal ArticlePregnancy in Congenital Adrenal Hyperplasia.
DOI:10.1016/j.ecl.2024.05.005 PMID: 39084815 -
Auchus RJ, Hamidi O, Pivonello R, Bancos I, Russo G, Witchel SF, Isidori AM, Rodien P, Srirangalingam U, Kiefer FW, Falhammar H, Merke DP, Reisch N, Sarafoglou K, Cutler GB, Sturgeon J, Roberts E, Lin VH, Chan JL, Farber RH, CAHtalyst Adult Trial Investigators . N Engl J Med, 2024 Aug 8; 391 (6): 504 - 514.Journal ArticlePhase 3 Trial of Crinecerfont in Adult Congenital Adrenal Hyperplasia.
DOI:10.1056/NEJMoa2404656 PMID: 38828955 -
Sarafoglou K, Kim MS, Lodish M, Felner EI, Martinerie L, Nokoff NJ, Clemente M, Fechner PY, Vogiatzi MG, Speiser PW, Auchus RJ, Rosales GBG, Roberts E, Jeha GS, Farber RH, Chan JL, CAHtalyst Pediatric Trial Investigators . N Engl J Med, 2024 Aug 8; 391 (6): 493 - 503.Journal ArticlePhase 3 Trial of Crinecerfont in Pediatric Congenital Adrenal Hyperplasia.
DOI:10.1056/NEJMoa2404655 PMID: 38828945 -
DeFronzo RA, Auchus RJ, Bancos I, Blonde L, Busch RS, Buse JB, Findling JW, Fonseca VA, Frias JP, Hamidi O, Handelsman Y, Pratley RE, Rosenstock J, Tudor IC, Moraitis AG, Einhorn D. BMJ Open, 2024 Jul 16; 14 (7): e081121Journal ArticleStudy protocol for a prospective, multicentre study of hypercortisolism in patients with difficult-to-control type 2 diabetes (CATALYST): prevalence and treatment with mifepristone.
DOI:10.1136/bmjopen-2023-081121 PMID: 39013654 -
Charoensri S, Auchus RJ. J Clin Endocrinol Metab, 2024 Jun 26;Journal ArticleResponse to Letter to the Editor From Tang and Zhang: "Predictors of Cardiovascular Morbidities in Adults With 21-Hydroxylase Deficiency Congenital Adrenal Hyperplasia".
DOI:10.1210/clinem/dgae402 PMID: 38922819 -
Charoensri S, Auchus RJ. Eur J Endocrinol, 2024 Jun 5; 190 (6): L11Journal ArticleResponse to letter from Dr. Al-Salameh.
DOI:10.1093/ejendo/lvae058 PMID: 38798229 -
Stuckey BGA, Dedic D, Zhang R, Rabbah A, Turcu AF, Auchus RJ. JCEM Case Rep, 2024 Jun; 2 (6): luae077Journal ArticleAbiraterone in Classic Congenital Adrenal Hyperplasia: Results of Medical Therapy Before Adrenalectomy.
DOI:10.1210/jcemcr/luae077 PMID: 38798742 -
Auchus R, Hamidi O, Pivonello R, Bancos I, Witchel S, Isidori A, Rodien P, Srirangalingam U, Kiefer F, Falhammar H, Merke D, Reisch N, Sturgeon J, Roberts E, Lin V, Chan JL, Farber R. Endocrine Abstracts,Journal ArticleBaseline characteristics of adults with classic congenital adrenal hyperplasia enrolled in CAHtalyst, a phase 3 study of Crinecerfont, a corticotropin-releasing factor type 1 receptor antagonist
DOI:10.1530/endoabs.99.p423
Department News
Dr. Rich Auchus at the University of Michigan Medical School was quoted in CNN article.